Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs
Purpose: Chromogranin A (CgA) and neuron-specific enolase (NSE) are important markers for neuroendocrine tumors; however, the clinical value of combining these markers has not been well studied. In this study, we investigated the utility of each marker individually and in combination for patients...
Main Authors: | Yang Lv, Xu Han, Chunyan Zhang, Yuan Fang, Ning Pu, Yuan Ji, Xuefeng Xu, Wenhui Lou, Dansong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2018-01-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | http://www.endocrineconnections.com/content/7/1/169.full |
Similar Items
-
Performance Evaluation of the KRYPTOR Compact PLUS Analyzer-Based B.R.A.H.M.S. CgA Ⅱ KRYPTOR Assay for Chromogranin A Measurement
by: Yu Jeong Choi, et al.
Published: (2021-12-01) -
Immunohistochemical investigation of neuroendocrine component in prostate adenocarcinoma
by: Prokopyk O. V., et al.
Published: (2010-01-01) -
High-soluble CGA levels are associated with poor survival in bladder cancer
by: T Szarvas, et al.
Published: (2019-05-01) -
Chromogranin A (CgA) as a marker of weaning in mechanically ventilated critically ill septic patients
by: Tayseer Zaytoun, et al.
Published: (2014-10-01) -
Serum NSE is Early Marker of Transformed Neuroendocrine Tumor After EGFR-TKI Treatment of Lung Adenocarcinoma
by: Mao X, et al.
Published: (2022-03-01)